IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 251-275 out of 1213.

<< < 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 > >>

Public Release: 15-Dec-2014
Journal of Health Psychology
People with low numeracy feel negative about taking part in bowel cancer screening
People who have problems with numbers may be more likely to feel negative about bowel cancer screening.
Cancer Research UK; NIH/National Institute for Health Research, Medical Research Council

Contact: Liz Smith
liz.smith@cancer.org.uk
020-346-98300
Cancer Research UK

Public Release: 15-Dec-2014
Nature
Joslin discovery may hold clues to treatments that slow aging
In a study published today by Nature, researchers at Joslin Diabetes Center used a microscopic worm, C. elegans, to identify a new path that could lead to drugs to slow aging and the chronic diseases that often accompany it -- and might even lead to better cosmetics.
National Institutes of Health

Contact: Jeffrey Bright
jeff.bright@joslin.harvard.edu
Joslin Diabetes Center

Public Release: 15-Dec-2014
JAMA Internal Medicine
Injuries from indoor tanning include burns, passing out, eye injuries
Skin burns, passing out and eye injuries were among the primary injuries incurred at indoor tanning sites and treated in emergency departments at US hospitals, according to a research letter published online by JAMA Internal Medicine.

Contact: Brittany Behm
media@cdc.gov
404-639-3286
The JAMA Network Journals

Public Release: 15-Dec-2014
2014 San Antonio Breast Cancer Symposium
Research: Two drugs before surgery help women with triple-negative breast cancer
A breast cancer specialist and clinical researcher at Women & Infants Hospital of Rhode Island presented research yesterday at the 2014 San Antonio Breast Cancer Symposium showing that adding either the chemotherapy drug carboplatin or the blood vessel-targeting drug bevacizumab to the standard treatment of chemotherapy before surgery helped women who have the basal-like subtype of triple-negative breast cancer.

Contact: Susan McDonald
slmcdonald@wihri.org
401-681-2816
Women & Infants Hospital

Public Release: 15-Dec-2014
Nature Genetics
Algorithm identifies networks of genetic changes across cancers
Using a computer algorithm that can sift through mounds of genetic data, researchers from Brown University have identified several networks of genes that, when hit by a mutation, could play a role in the development of multiple types of cancer. The researchers hope the new genetic insights might aid in the development of new drugs and treatment approaches for cancer.
National Science Foundation, National Institutes of Health

Contact: Kevin Stacey
kevin_stacey@brown.edu
401-863-3766
Brown University

Public Release: 15-Dec-2014
Annals of Internal Medicine
News from Dec. 16, 2014 Annals of Internal Medicine
This issue of Annals of Internal Medicine includes: 'Earlier detection could close the race gap on colon cancer deaths'; 'Emphysema on CT an important independent risk factor for death'; and 'Patient feelings about consent for use of personal medical data: It's complicated.'

Contact: Megan Hanks
mhanks@acponline.org
215-351-2656
American College of Physicians

Public Release: 15-Dec-2014
Pediatrics
Teen use of e-cigarettes growing; Hawaii use rates higher than in mainland
E-cigarette use among teenagers is growing in the US, and Hawaii teens take up e-cigarette use at higher rates than their mainland counterparts, a new study by University of Hawaii Cancer Center researchers has found.
NIH/National Cancer Institute

Contact: Stacy Wong
swong@cc.hawaii.edu
808-356-5753
University of Hawaii Cancer Center

Public Release: 15-Dec-2014
Proceedings of the National Academy of Sciences
Too much, too little, just right
Scientists have long known the p53 protein suppresses tumors. However, a recent animal study by UC Davis researchers has uncovered a complicated relationship between p53 and another protein, Rbm38, highlighting how the body calibrates protein levels.
National Institutes of Health

Contact: Dorsey Griffith
dorsey.griffith@ucdmc.ucdavis.edu
916-734-9118
University of California - Davis Health System

Public Release: 15-Dec-2014
Nature Nanotechnology
Promising new method for rapidly screening cancer drugs
Traditional genomic, proteomic and other screening methods currently used to characterize drug mechanisms are time-consuming and require special equipment, but now researchers led by chemist Vincent Rotello at the University of Massachusetts Amherst offer a multi-channel sensor method using gold nanoparticles that can accurately profile various anti-cancer drugs and their mechanisms in minutes.
NIH/Institute for General Medical Sciences, National Science Foundation's Center for Hierarchical Manufacturing at UMass Amherst.

Contact: Janet Lathrop
jlathrop@admin.umass.edu
413-545-0444
University of Massachusetts at Amherst

Public Release: 15-Dec-2014
Biomedical Optics Express
Potential new tool for cervical cancer detection and diagnosis
A team of researchers from Central South University in China have demonstrated that a technique known as photoacoustic imaging, which is already under investigation for detecting skin or breast cancers and for monitoring therapy, also has the potential to be a new, faster, cheaper and noninvasive method to detect, diagnose and stage cervical cancer with high accuracy. Their work appears in a new paper in the Optical Society journal Biomedical Optics Express.

Contact: Jason Socrates Bardi
jbardi@aip.org
240-535-4954
The Optical Society

Public Release: 15-Dec-2014
eLife
Proteins drive cancer cells to change states
A new study from the Massachusetts Institute of Technology implicates a family of RNA-binding proteins in the regulation of cancer, particularly in a subtype of breast cancer.
National Institutes of Health

Contact: Sarah McDonnell
s_mcd@mit.edu
617-253-8923
Massachusetts Institute of Technology

Public Release: 15-Dec-2014
Personality and Social Psychology Bulletin
War metaphors for cancer hurt certain prevention behaviors
It's not unusual for people to use war metaphors such as 'fight' and 'battle' when trying to motivate patients with cancer.

Contact: Jared Wadley
jwadley@umich.edu
734-936-7819
University of Michigan

Public Release: 15-Dec-2014
Genetic Testing and Molecular Biomarkers
New colorectal cancer risk factor identified
Adiponectin, a collagen-like protein secreted by fat cells, derives from the ADIPOQ gene. Variations in this gene may increase risk for type 2 diabetes, cardiovascular disease, and various cancers. A new study that links specific variations in the ADIPOQ gene to either higher or lower colorectal cancer risk is published in Genetic Testing and Molecular Biomarkers.

Contact: Kathryn Ryan
kryan@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 15-Dec-2014
BBA Molecular Cell Research
If cells can't move ... cancer can't grow
By blocking a widespread enzyme, Centenary researchers have shown they can slow down the movement of cells and potentially stop tumors from spreading and growing.
Rebecca L. Cooper Medical Research Foundation, Australian Government, University of Sydney, Cancer Institute NSW, Perpetual Trustees, Clive and Vera Ramaciotti Foundation

Contact: Toni Stevens
toni@scienceinpublic.com.au
61-401-763-130
Centenary Institute

Public Release: 15-Dec-2014
Nature Communications
Signaling mechanism could be target for survival, growth of tumor cells in brain cancer
UT Southwestern Medical Center neurology researchers have identified an important cell signaling mechanism that plays an important role in brain cancer and may provide a new therapeutic target.
National Institutes of Health, US Department of Veterans Affairs, William and Sylvia Zale Foundation, Ethel Silvergold Philanthropic Fund of the Dallas Jewish Community Foundation, Barbara F. Glick

Contact: Russell Rian
russell.rian@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center

Public Release: 15-Dec-2014
Nature Materials
Molecular 'hats' allow in vivo activation of disguised signaling peptides
When someone you know is wearing an unfamiliar hat, you might not recognize them. Georgia Institute of Technology researchers are using just such a disguise to sneak biomaterials containing peptide signaling molecules into living animals.
National Science Foundation, National Institutes of Health

Contact: John Toon
jtoon@gatech.edu
404-894-6986
Georgia Institute of Technology

Public Release: 14-Dec-2014
Genes & Development
Baby cells learn to communicate using the Lsd1 gene
New research shows that infant cells have to go through a developmental process that involves specific genes before they can take part in the group interactions that underlie normal cellular development and keep our tissues functioning smoothly. The existence of a childhood state where cells cannot communicate fully has potentially important implications for our understanding of how gene activity on chromosomes changes both during normal development and in cancerous cells.
Howard Hughes Medical Institute

Contact: Allan Spradling
spradling@ciwemb.edu
Carnegie Institution

Public Release: 12-Dec-2014
Cell Reports
A control knob for fat?
Researchers found a new function for a long-studied gene: it appears to regulate fat storage in C. elegans.
NIH/National Institutes of Health, American Heart Association, The Ellison Medical Foundation, American Federation of Aging Research

Contact: Robert Perkins
perkinsr@usc.edu
213-740-9226
University of Southern California

Public Release: 12-Dec-2014
2014 San Antonio Breast Cancer Symposium
Male and female breast cancers are not identical
Results of the EORTC10085/TBCRC/BIG/NABCG International Male Breast Cancer Program conducted in both Europe and in the United States and presented at the 2014 San Antonio Breast Cancer Symposium found significant improvement in survival for men with breast cancer, but this improvement was not as good as that observed for women. The study, which included 1822 men treated for breast cancer between 1990 and 2010, provides much needed information about the clinical and biological characteristics of male breast cancer.
Breast Cancer Research Foundation, European Organisation for Research and Treatment of Cancer Breast Cancer Group, Dutch Pink Ribbon, European Breast Cancer Conferences Council, Swedish Breast Cancer Association, Susan G. Komen For the Cure

Contact: John Bean
john.bean@eortc.be
European Organisation for Research and Treatment of Cancer

Public Release: 12-Dec-2014
Journal of the National Cancer Institute
Migraine was not associated with BC in a pooled analysis of prospective cohort studies
Migraine was not associated with breast cancer risk or differences in the endogenous sex hormones that have been proposed to be associated with migraines, according to a new study published Dec. 12 in the JNCI: Journal of the National Cancer Institute.

Contact: Zachary Rathner
Zachary.Rathner@oup.com
919-677-2697
Oxford University Press USA

Public Release: 12-Dec-2014
Proceedings of the National Academy of Sciences
MBL imaging technique reveals that bacterial biofilms are associated with colon cancer
An imaging technology developed at MBL reveals that bacterial biofilms are associated with colon cancer. Reported in PNAS with lead authors from Johns Hopkins Medical Institutions.
National Institutes of Health, Merieux Foundation

Contact: Diana Kenney
dkenney@mbl.edu
508-289-7139
Marine Biological Laboratory

Public Release: 11-Dec-2014
Journal of Clinical Oncology
Youngest bone marrow transplant patients at higher risk of cognitive decline
Toddlers who undergo total body irradiation in preparation for bone marrow transplantation are at higher risk for a decline in IQ and may be candidates for stepped up interventions to preserve intellectual functioning, St. Jude Children's Research Hospital investigators reported. The findings appear in the current issue of the Journal of Clinical Oncology.
National Institutes of Health, ALSAC

Contact: Carrie Strehlau
carrie.strehlau@stjude.org
901-595-2295
St. Jude Children's Research Hospital

Public Release: 11-Dec-2014
Neuro-Oncology
Scientists define important gene interaction that drives aggressive brain cancer
Targeted therapies are a growing and groundbreaking field in cancer care in which drugs or other substances are designed to interfere with genes or molecules that control the growth and survival of cancer cells. Now, scientists at Virginia Commonwealth University Massey Cancer Center have identified a novel interaction between a microRNA and a gene that could lead to new therapies for the most common and deadly form of brain tumor, malignant glioma.

Contact: John Wallace
wallacej@vcu.edu
804-628-1550
Virginia Commonwealth University

Public Release: 11-Dec-2014
Molecular Cell
MSU scientists find way to boost healthy cells during chemo
Michigan State University scientists are closer to discovering a possible way to boost healthy cell production in cancer patients as they receive chemotherapy. By adding thymine -- a natural building block found in DNA -- into normal cells, they found it stimulated gene production and caused them to multiply.
US Department of Defense, NIH/National Cancer Institute

Contact: Sarina Gleason
sarina.gleason@cabs.msu.edu
517-355-9742
Michigan State University

Public Release: 11-Dec-2014
Aging
New discoveries in age-related macular degeneration revealed in industry and academia
Insilico Medicine along with scientists from Vision Genomics and Howard University shed light on AMD disease, introducing the opportunity for eventual diagnostic and treatment options.

Contact: Michael Petr
michael.petr@insilicomedicine.com
InSilico Medicine, Inc.

Showing releases 251-275 out of 1213.

<< < 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 > >>

  Search News Releases

     

 

EurekAlert!